Sunil Healthcare to expand production capacity of Empty Hard Gelatin Capsule

Sunil Healthcare soared on the NSE by nearly 4.3% as the company on Thursday’s post hours said that the board of directors of the company approved the plan for expansion.

May 19, 2017 06:05 IST India Infoline News Service

Sunil Healthcare soared on the NSE by nearly 4.3% as the company on Thursday’s post hours said that the board of directors of the company approved the plan for expansion.
 
The company in its filing to the exchanges added that the board has approved the expansion plan of production capacity of Empty Hard Gelatin Capsule from 11 billion to 13 billion approximately p.a. for the financial year 2017-18.
 
The stock has delivered negative returns of 20% on the NSE in a period of one year and has underperformed the BSE Small cap and the BSE Healthcare indices over the same time period.
 
The stock had hit its 52-week high of Rs 122 per share on May 27, 2016, and hit its 52-week low of Rs 70.75 per share on November 9, 2017, o the BSE.


Stock view:
 
Sunil Healthcare Ltd is currently trading at Rs 92, up by Rs 1 or 1.1% from its previous closing of Rs 91 on the BSE.
 
The scrip opened at Rs 91 and has touched a high and low of Rs 95.95 and Rs 91 respectively. So far 908(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 93.32 crore.
 
The BSE group 'XD' stock of face value Rs 10 has touched a 52 week high of Rs 122 on 27-May-2016 and a 52 week low of Rs 70.75 on 09-Nov-2016. Last one week high and low of the scrip stood at Rs 98 and Rs 90 respectively.
 
The promoters holding in the company stood at 73.53 % while Institutions and Non-Institutions held 0.1 % and 26.37 % respectively.
 
The stock is currently trading below its 50 DMA.

Related Story